“Mitochondria—the powerhouse of the cell.”
It’s almost a reflex. Say the word, and a chorus of voices answers back with the same rehearsed phrase, learned sometime between middle school biology and standardized exams.
From a molecular forensic science perspective, mitochondria carry a slightly different weight.
Cue the crime scene.
Yellow tape. Blood spatter. A single strand of hair on the floor. Television would have you believe that’s enough—a quick swab, something that vaguely resembles a centrifuge, and suddenly a clean facial composite materializes on screen.
In reality, a single shed hair is rarely that cooperative.
Nuclear DNA exists in only two copies per cell—limited in quantity, and in most forensic samples, degraded beyond recovery. This is where mitochondria become indispensable. Each cell contains between 1,000 and 10,000 mitochondria, each carrying its own copy of mtDNA. Not one safe house, but thousands. The double membrane offers protection against environmental degradation that the nucleus simply doesn’t have.1-4
The catch is maternal inheritance. Mitochondrial DNA narrows a suspect pool—it never pinpoints. Useful. But not conclusive.1-4
That same duality carries directly into medicine.
Mitochondrial diseases affect more than 1 in 5,000 individuals. The clinical spectrum is brutal: Leigh syndrome, MELAS, mtDNA depletion syndrome, progressive neurodegeneration. Because mitochondria sit at the center of cellular energy metabolism, a dysfunctional organelle doesn’t quietly cause one problem. It unravels everything downstream.5-6
Current treatment is largely symptomatic. We manage, we supplement, we slow the decline. We do not fix it.6
CRISPR-Cas9, the molecular scalpel that has rewritten our expectations for genetic disease, has largely left mitochondrial DNA alone. The same double membrane that protects mtDNA in a forensic sample also blocks editing machinery from getting inside. For years, we have been able to replace entire organs more reliably than we could edit the smallest genomes within our own cells.5,7
So the field began asking a different question: what if we just replaced them?
The concept is almost embarrassingly intuitive. Medicine already accepts this logic at scale—kidney, liver, heart, end-stage failure, transplant, function restored. If we can transplant organs and entire microbial ecosystems, why not the organelles themselves?
The problem was always delivery. Freely injected mitochondria rapidly lose their membrane potential, the electrochemical gradient across the inner membrane that marks a healthy, functional organelle. Cells recognize depolarized mitochondria as damaged and destroy them. Previous approaches required doses that would be clinically impractical at human scale. The efficiency was too low. The attrition too high.8-9
Du et al., published in Cell just last month, proposed an elegant workaround: wrap the mitochondria first.
The approach encapsulates donor mitochondria within red blood cell plasma membrane vesicles roughly 1 micron in diameter. Erythrocytes are ideal: no nucleus, no competing organelles, immunologically well-characterized. Encapsulation preserves membrane potential far better than free delivery, because that gradient is not merely structural. It is the signal that distinguishes a functional mitochondrion from debris.
Once delivered, transplanted mitochondria enter recipient cells, fuse into the host mitochondrial network, and integrate within 48 hours. Efficiency reached approximately 80% in cell culture, compared to negligible rates with free mitochondria.
The effects were not subtle. Cells stripped entirely of their own mtDNA recovered. DNA levels restored to nearly healthy baselines, held for at least three weeks, with oxygen consumption and ATP production climbing back toward normal. In patient-derived cells carrying the m.3243A>G mutation, the proportion of mutant copies dropped from 92.6% to 73.3%, which is a meaningful shift, given that mitochondrial disease doesn’t fully manifest until mutant mtDNA crosses a critical threshold within the cell. In mice modeling Leigh syndrome, treated animals lived longer and moved better. In a Parkinson’s model, a single targeted injection rescued dopamine-producing neurons and restored motor function for at least three months.10
Not correction. Not compensation.
Replacement.
This is still preclinical work, and the authors are candid about it. Targeted tissue delivery remains unsolved. Clinical translation requires substantial optimization. But for diseases where treatment has historically meant managing decline, the conceptual shift alone is significant.
But I keep returning to where I first learned to think about mitochondria.
A strand of hair. A degraded sample. A signal that is abundant, but not specific.
Because if mitochondrial transplantation becomes clinically viable—if donor mitochondria integrate, persist, and replicate—then mitochondrial DNA no longer reflects a single, unbroken maternal lineage.
Which raises a question that has nothing to do with efficacy or safety profiles or phase one trials.
What happens if a patient, carrying transplanted mitochondria, sheds a hair…
in the wrong place…
…at the wrong time?
References
- Amorim A, Fernandes T, Taveira N. Mitochondrial DNA in human identification: a review. PeerJ. 2019 Aug 13;7:e7314. doi: 10.7717/peerj.7314. PMID: 31428537; PMCID: PMC6697116.
- Kim H, Erlich HA, Calloway CD. Analysis of mixtures using next generation sequencing of mitochondrial DNA hypervariable regions. Croat Med J. 2015 Jun;56(3):208-17. doi: 10.3325/cmj.2015.56.208. PMID: 26088845; PMCID: PMC4500979.
- Pfeiffer, H., Hühne, J., Ortmann, C., Waterkamp, K., & Brinkmann, B. (1999). Mitochondrial DNA typing from human axillary, pubic and head hair shafts – success rates and sequence comparisons. International Journal of Legal Medicine, 112(5), 287-290. doi:https://doi.org/10.1007/s004140050251
- Kim, B. M., Hong, S. R., Chun, H., Kim, S., & Shin, K. (2020). Comparison of whole mitochondrial genome variants between hair shafts and reference samples using massively parallel sequencing. International Journal of Legal Medicine, 134(3), 853-861. doi:https://doi.org/10.1007/s00414-019-02205-y
- Russell OM, Gorman GS, Lightowlers RN, Turnbull DM. Mitochondrial Diseases: Hope for the Future. Cell. 2020 Apr 2;181(1):168-188. doi: 10.1016/j.cell.2020.02.051. Epub 2020 Mar 26. PMID: 32220313.
- Grier J, Hirano M, Karaa A, Shepard E, Thompson JLP. Diagnostic odyssey of patients with mitochondrial disease: Results of a survey. Neurol Genet. 2018 Mar 26;4(2):e230. doi: 10.1212/NXG.0000000000000230. PMID: 29600276; PMCID: PMC5873725.
- Silva-Pinheiro P, Minczuk M. The potential of mitochondrial genome engineering. Nat Rev Genet. 2022 Apr;23(4):199-214. doi: 10.1038/s41576-021-00432-x. Epub 2021 Dec 2. PMID: 34857922.
- Borcherding N, Brestoff JR. The power and potential of mitochondria transfer. Nature. 2023 Nov;623(7986):283-291. doi: 10.1038/s41586-023-06537-z. Epub 2023 Nov 8. PMID: 37938702; PMCID: PMC11590279.
- Jiao H, Jiang D, Hu X, Du W, Ji L, Yang Y, Li X, Sho T, Wang X, Li Y, Wu YT, Wei YH, Hu X, Yu L. Mitocytosis, a migrasome-mediated mitochondrial quality-control process. Cell. 2021 May 27;184(11):2896-2910.e13. doi: 10.1016/j.cell.2021.04.027. PMID: 34048705.
- Du S, Long Q, Zhou Y, Fu J, Wu H, Yang L, Xie Y, Ding Y, Zhang M, Guo J, Wang M, Lin J, Hu M, Zhang J, Yao D, Li W, Bao F, Xiang G, Wu Y, Huang Y, Liang H, Wang R, Li H, Chen B, Li C, Wang J, Zhang J, Qin D, Sun J, Zhu Y, Sun F, Wang W, Lu G, Chan WY, Zhao H, Liu C, Liu X. Transplantation of encapsulated mitochondria alleviates dysfunction in mitochondrial and Parkinson’s disease models. Cell. 2026 Mar 18:S0092-8674(26)00230-8. doi: 10.1016/j.cell.2026.02.023. Epub ahead of print. PMID: 41856111.
Hanna Kim
Hanna Kim is a fourth-year medical student at the University of Arizona College of Medicine – Phoenix. She appreciates writing for its powerful ability to heal and enjoys exploring the intersection of medicine and patient storytelling. Outside of studying and clinical rotations, Hanna loves getting creative in the kitchen—whether it’s testing new recipes for a fun gathering or perfecting her meal prep skills—and exploring Arizona’s beautiful hiking trails (when it's below 100 F!). She welcomes connections and can be reached athannakim1@arizona.edu.